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Abstract.  Cell surface carbohydrate structures acting 
as ligands for tissue specific mammalian lectins have 
been implicated in cell-cell interactions during em- 
bryogenesis, lymphocyte homing, and tumor cell 
metastasis. In this report,  we provide evidence that 
/31-4 linked galactose (Gal) residues in N-linked 
oligosaccharides on the surface of blood born tumor 
cells serve as a ligand for binding to microvascular en- 
dothelial cells. D36W25,  a class  1 glycosylation mu- 
tant of the MDAY-D2 lymphoreticular tumor cell line, 
lacks sialic acid and Gal in cellular glycans due to a 
defect in the Golgi UDP-Gal transporter.  Using UDP- 
Gal and bovine galactosyltransferase in vitro, ill-4 Gal 
was restored to the surface of the cells and 70%  of 
the galactosylated glycans persisted for 8 h  in vitro at 
37°C.  Compared to mock-treated D36W25  cells, 
galactosylated D36W25  ceils showed an 80%  increase 
in binding to microvascular endothelial cell mono- 
layers in vitro. The enhanced binding of galactosylated 
D36W25  cells to endothelial cell was inhibited by the 
addition of lactosamine-conjugated albumin to the as- 
say. Consistent with these observations, swainsonine 
and castinospermine, two inhibitors of N-linked pro- 
cessing that result in loss of lactosamine antennae in- 
hibited the binding of wild-type MDAY-D2 cells to en- 
dothelial cells in vitro. Injection of radiolabeled tumor 
cells into the circulation of syngeneic mice, showed 
that galactosylation of D36W25  cells resulted in 2-3 
more tumor cells retained in the lungs and livers.  In 
addition, galactosylation of D36W25  cells increased by 
30-fold the number of visible liver metastases on in- 
spection 4  wk after tumor cell injection. These results 
suggest that fll-4Gal-binding lectins on microvascular 
endothelial cells can contribute to retention and sec- 
ondary tumor formation of blood born tumor cells. 
With the increasing availability of purified glycosyl- 
transferases, reconstruction of a variety of carbohy- 
drate sequences on the surface of class 1 mutants 
provides a controlled means of studying carbohydrate- 
lectin interactions on viable cells. 
C 
ELL surface  carbohydrates  on lymphocytes and  en- 
dothelial  cells have been implicated  in lymphocyte 
homing to specific tissues, presumably due to their 
recognition by mammalian lectins (Stoolman et al.,  1984; 
Gallatin et al., 1986; Aizawa and Tavassoli, 1988). For ex- 
ample, mannose-6-P has been shown to inhibit lymphocyte 
homing to lymph node and attachment to high endothelium 
of postcapillary  venules (Stoolman et al.,  1984). Gal-BSA 
and asialofetuin inhibited homing of murine lymphocytes to 
the bone marrow (Aizawa and Tavassoli, 1988). Galactose 
(Gal)t-binding lectins have been identified on bone marrow 
endothelial cells (Kataoka and Tavassoli, 1985) and may be 
important in organ retention and colonization by blood born 
tumor cells.  In this regard,  intravenous infusion of Gal or 
arabinogalactan  has been shown to inhibit organ coloniza- 
tion by murine tumor cells (Beuth et al., 1987). Antibodies 
1.  Abbreviations  used in this paper:  BCE,  bovine capillary endothelial; 
BSII,  Bandereia  simplicifolia;  FACS,  fluorescence-activated  cell sorter; 
Gal, o-galactose; GaI-T, galactosyl transferase; HSA, human serum albu- 
min; L-PHA, leucoagglutinin; WGA, wheat germ agglutinin. 
specific for Galotl-3Gal, a sequence that is often expressed 
in human breast carcinomas, have been shown to reduce tu- 
mor cell adhesion to human cord endothelium (Castronovo 
et al., 1989). A variety of Gal-binding lectins has also been 
isolated from mammalian tissues (Sparrow et al., 1987; Hi- 
nek et al., 1988; Raz, 1987). More recently, the determina- 
tion of primary sequences of several mammalian lectins and 
their carbohydrate recognition domains has lead to the iden- 
tification of other putative lectins based on sequence homol- 
ogies (Drickamer, 1988). Two cell adhesion receptors desig- 
nated ELAM-1 and GMP-140 have recently been identified 
in endothelial cells, and both show sequence homology with 
the C-type animal lectins (Bevilacqua et al., 1989; Johnston 
et al., 1989). However, the carbohydrate-binding specificity 
of these receptors and the importance  of these domains for 
lymphocyte  and tumor cell  adhesion  remain  to be deter- 
mined. 
We have used a glycosylation mutant of the highly meta- 
static lymphoreticular  tumor cell line MDAY-D2 (Dennis, 
1986a,b) as well as N-linked processing inhibitors, swainso- 
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Figure 1. Schematic of  the major N-linked oligosaccharides in MDAY-D2 and D36W25 mutant tumor cells as determined previously (Dennis 
et al., 1986a). The consequences of swainsonine (SW)- and castinospermine (Cast)-treatment as well as the resulting structure on D36W25 
cells after treatment with bovine Gal-T and UDP-Gal  are shown.  The latter assumes the complete  substitution of GlcNAc-termini on 
complex-type oligosaccharide of D36W25 cells. 
nine and castinospermine (Elbein, 1987), to assess the con- 
tribution of complex type N-linked structures in tumor cell 
attachment to endothelial cells in vitro. The results suggest 
that loss of lactosamine antennae of N-linked oligosaccharides 
is associated with a reduction in cell adhesion to endothelial 
cells in vitro. However, somatic mutations and chemical in- 
hibitors of oligosaccharide processing affect intraceUular as 
well as cell surface glycoproteins and may induce secondary 
changes  affecting cell surface phenomena.  Therefore, we 
have developed a model system to reconstruct oligosaccha- 
ride structures on the  surface of viable tumor cells using 
purified glycosyltransferases and sugar-nucleotide donors. A 
similar approach has been used to define the specificity of 
hemagglutinins from influenza virus for sialyllactose. Neur- 
aminidase-treated erythrocytes were reconstituted with vari- 
ous types of sialic acid in either ot2-6 or ot2-3 linkages using 
purified sialyltransferase (Paulson et al.,  1979;  Higa and 
Paulson, 1985). In the present study, we have used D36W25, a 
poorly metastatic class 1 glycosylation mutant of the MDAY- 
D2 tumor cell line that lacks Gal and sialic acid. The mutant 
cells produce truncated glycoconjugates, mainly tetra-an- 
tennary N-linked with only GlcNAc as antenna (Fig. 1). We 
have restored the/~l-4Gal to the N-linked oligosaccharides 
on the surface of the mutant tumor cells using bovine galac- 
tosyltransferase (Gal-T) to determine whether the monosac- 
charide residue mediate tumor cell adhesion to vascular en- 
dothelial  cells  and  increase  organ  colonization by  blood 
borne tumor cells. 
Materials and Methods 
Cell Lines 
MDAY-D2 is a highly metastatic lymphosarcoma tumor cell line of DBA/2 
origin (Kerbel et al.,  1980).  D36W25 was isolated in a  single step from 
MDAY-D2  cells  without  mutagenic  treatment  by  selection  in  growth 
medium containing wheat germ agglutinin (WGA) as previously described 
(Lagarde et al., 1983).  The cells were maintained in u-MEM plus 5% FCS 
(Gibco  Laboratories,  Grand  Island,  NY).  Bovine capillary  endothelial 
(BCE) cells, provided by Dr. J. Folkman, were obtained from the adrenal 
gland and were cultured on gelatin-coated plates in DME (Gibco Laborato- 
ries),  supplemented with  10%  FCS and  120  #g/ml endothelial mitogen 
(Biomedical Technologies, Inc., Cambridge, MA) in a  10%  CO2 atmos- 
phere. 
Treatments with Glycosylation Inhibitors 
The cells were cultured for 1 wk in the presence of 1/~g/ml of chemically 
synthesized swainsonlne (Toronto Research Chemicals, Toronto, Ontario) 
and 20 #g/ml castinospermine (Sigma Chemical Co., St.  Louis,  MO). 
These inhibitors do not reduce the plating efficiency of the tumor cells at 
these concentrations (VanderElst, I., and J. W. Dennis, manuscript submit- 
ted for publication). The drug concentrations and a 48-h incubation have 
previously been shown to be optimal for inhibition of oligosaccharide pro- 
cessing in MDAY-D2 cells (Dennis, 1986a,b). However, inhibition of pro- 
cessing has previously been shown to be incomplete (i.e., 80-90%) (Elbein 
et al.,  1987). 
Tumor Cell Adhesion to Endothelial Cells 
BCE cells were seeded into gelatin-coated 24-well plates (Costar, Cam- 
bridge, MA) and cultured until the cells were confluent. Passage 15 and 18 
cultures were used for adhesion assays and only after they reached conflu- 
ence.  Tumor  cells  were labeled with 2  ttCi/ml  [3H]thymidine (25  Ci/ 
mmol; Amersham Corp., Arlington Heights, IL) for 24 h, washed 3x  in 
serum-free medium (DME) and adjusted to a concentration of 105 cells/ml 
in the adhesion medium made of 10 mM Hepes-buffered DME plus 1% 
BSA. Endothelial monolayers were washed once and incubated for 2 h in 
adhesion medium. One milliliter of tumor cells was added to test wells, and 
the cultures were placed on a rotating platform maintained at 37°C in 5% 
C(h.  A  rotational  speed Of 100  rpm was used as previously described 
(Ally and Auerbach, 1984).  After various incubation times, the wells were 
gently rinsed 4×  with adhesion medium at 37°C, and the attached cells 
were lysed in 0.2 ml 1N NaOH. The lysates were neutralized with 0.2 ml 
1N HC1 and radioactivity was assessed in a/3 scintillation counter (LKB 
Instruments,  Gaithersburg,  MD).  The neoglycoprotein Gal/~l-4GlcNAc- 
coupled to HSA (provided by Dr. Y. Sommadn (Biocarb, Lurid, Sweden)) 
166 ~g/ml was added in 0.5 ml DME,  1% BSA 15 rain before adding 105 
tumor cells in 0.5 ml of the same medium. The molar ratio of Gal to HSA 
was 15-20. 
Galactosylation of Viable D36W25 Cells 
Galactosylation was performed using conditions similar to those previously 
described for lymphocytes (Torres and Hart,  1984).  D36W25  cells were 
washed twice in PBS and once in the reaction buffer (10 mM Hepes [pH 
7.3], and 150 mM NaC1). The optimized conditions for galactosylation were 
107 cells/ml in 5 mM D-galactose,  2.5  mM MnC12, 25  mM Hepes (pH 
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bovine galactosyltransferase (Boehringer Mannheim Biochemicals, Indi- 
anapolis, IN)  for 20 min at 37°C.  The enzyme was stored in 2.5  mM 
MnCI2 and 25 mM Hepes. In experiments designed to optimize the reac- 
tion conditions, 5 #Ci of radioactive UDP-[3H]galactose (17.3 Ci/mmol; 
Amersham Corp.) was added to a 100-#l reaction mixture. The reaction was 
terminated by placing the tubes on ice and washing the cell pellet 3 x  in cold 
PBS. The cell pellets were lysed in 0.2 ml 1 M NaOH, neutralized with 0.2 
ml  1 M  HCI  and counted with a  B scintillation counter.  Mock-treated 
D36W25 cells were incubated in the same reaction buffer with the omission 
of Gal-T.  Omission of GaI-T or UDP-Gal produced the same results. 
SDS Gel Electrophoresis 
SDS-PAGE separation of glycoproteins was performed with 12.5% poly- 
acrylamide gels (Laemmli, 1970).  Ceils were lysed in 0.5% Triton X-100, 
2  mM  PMSF  and 0.1%  tranylol  and  an  equivalent of 2  x  10  s  [3H]- 
galactosylated cells was loaded onto the gel that was subsequently fixed, 
stained with Coomassie blue, treated with enhancer (Biotechnology Sys- 
tem), dried, and exposed to x-ray film for 4 d. 
Lectin Binding and Quantitation by 
Fluorescence-activated Cell Sorter (FACS) 
Cells were suspended at 5  x  105/50 #l of PBS, 1% BSA and 50 #l of lectin 
in the same buffer was added. The final lectin concentrations used were 
2/~g/ml for L-PHA (Sigma Chemical Co.) and 4  #g/ml for BSII lectin 
(Sigma Chemical Co.). The cells were incubated for 1 b at 4°C in the pres- 
ence of lectin, washed 3 x  in PBS-BSA, and resuspended with rabbit an- 
tilectin antibodies  (1/1,000)  prepared in  our  laboratory  (Dennis et  al., 
1989). After 30-rain incubation at 4"C, the cells were washed twice in PBS- 
BSA and incubated in a 1:100 dilution of F1TC-conjugated anti-rabbit anti- 
body (Cappel Laboratories, Malvern, PA) for 30 rain. The final washes 
were performed in PBS, the cells were then fixed in 1% buffeted paraform- 
aldehyde and were subjected to cytofluorimetry analysis using a fluores- 
cence-activated cell ~orter (EPICS-C; Coulter Electronics, Hialeah, FL). 
To estimate the half-life of galactosylated cell surface glycoproteins, galac- 
tosylated D36W25 cells were cultured in DME with 1% BSA at 37°C and 
at intervals the cells were washed in cold PBS-BSA and reacted with BSII 
lectin at 4°C as described above and analyzed by FACS. 
Organ Retention Assay 
Tumor cells were labeled with 2/zCi/ml of [12sI]UdR (5 Ci/mg; Amersham 
Corp.)  for 24 h.  The cells were then galactosylated, and  105 control or 
galactosylated D36W25  cells were injected into the lateral tail vein of syn- 
geneic male DBA/2 mice. At different intervals, three mice per group were 
killed and their lungs and livers were collected, washed for 48 h in three 
changes of 70% ethanol to remove soluble 125I. The remaining ethanol in- 
soluble radioactivity was associated with the DNA of viable tumor cells in 
the organs (Hart and Fiddler, 1980) and was measured in a "r counter (LKB 
Instruments, Inc., Gaithersburg, MD). 
Organ Colonization Assay 
Tumor cells (105/mouse)  in 0.5 ml of PBS were injected into lateral tail 
vein  of  DBA/2  mice.  Mice  injected  with  galaetosylated  and  control 
D36W25  cells were sacrificed and autopsied at 4 wk. Mice injected with 
MDAY-D2 cells were sacrificed at 3 wk because of the more aggressive na- 
ture of these tumor cells. In all experiments, the quality of the galactosyla- 
tion was confirmed by BSH lectin binding and FACS analysis. 
Results 
Adhesion of  MDAY-D2 to Endothelial Cells Is 
Reduced by the Class I Mutation, Swainsonine, 
and Castinospermine 
Initial experiments comparing the adhesion of MDAY-D2 
cells and the class 1 mutant to confluent monolayers of bo- 
vine microvascular endothelial cells showed that the mutant 
cells D36W25 were ~9x  less adhesive after 25 min (Fig. 
2). Visual examination of the cultures during the endothelial 
cell adhesion assay indicated that homotypic aggregation of 
tumor cells did not occur. Similar results were obtained for 
adhesion to human cord endothelial cells (data not shown). 
The class 1 mutation results in almost complete loss of Gal- 
containing oligosaccharides in glycoproteins and glycolip- 
ids. A more selective loss of carbohydrate sequences in the 
antennae of N-linked complex type oligosaccharides can be 
induced by growing the MDAY-D2 tumor cells in the pres- 
ence of  the glycosylation  inhibitors swainsonine and castano- 
spermine. Swainsonine inhibits c~-mannosidase  II resulting 
in the synthesis of hybrid type oligosaccharides rather than 
complex type. Castanospermine inhibits glucosidase I and 
cells grown in the presence of the drug produce oligosaccha- 
rides of the high mannose type (Fig.  1).  MDAY-D2 cells 
grown in the presence of either drug for 48 h before the en- 
dothelial cell adhesion assay showed a two- to threefold loss 
in adhesiveness after 25 rain (Fig. 2). Visual examination of 
the cultures during the endothelial cell adhesion assay indi- 
cated that homotypic aggregation of tumor cells did not oc- 
cur. These results suggest that a significant component of the 
adhesive interaction between MDAY-D2 cells and endothe- 
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Figure 2. Tumor cell adhesion to bovine capillary en- 
dothelial monolayers  in  vitro.  (o)  MDAY-D2  cells; 
(o) swainsonine-treated MDAY-D2 cells; (v) castano- 
spermine-treated MDAY-D2 cells; and (u) D36W25. 
Values are expressed as a percent of total cells added 
per well.  Error bars represent SD of triplicates. 
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Figure 3. Optimization of the conditions for galactosylation of D36W25 cells. (A) UDP-Gal concentration. 2  x  105 D36W25 cells (e) 
or MDAY-D2 cells (-) were incubated with 5 #Ci UDP-[3H]Gal, 0-200 #M cold UDP-Gal, and 900 mU/ml bovine Gal-T for 30 min. 
(B) GaI-T concentration. 2  x  105 D36W25 cells were incubated with the optimal 150 ttM UDP-galactose concentration in presence of 
5 ttCi UDP-[3H]Gal  and 0-1,200 mU/ml GaI-T for 30 min. (C) Cell number. 0-2 ×  106 D36W25 cells were incubated with 5/zCi UDP 
[3H]Gal, 150 #M UDP-Gal, and 900 mU/ml GaI-T for 30 min. (D) Incubation time. 2  x  105 cells were incubated with 5/~Ci  UDP- 
[3H]Gal, 150/~M UDP-Gal, and 900 mU/ml GaI-T for 5-30 min. 
lial cells requires the expression of complex type N-linked 
oligosaccharides. 
Exogenous Galactosylation of Truncated N-linked 
Oligosaccharides on D36W25 Cell 
The antennae  in  N-linked  oligosaccharides  of MDAY-D2 
cells are lactosamine and polylactosamine that terminate in 
either SAct2-3Gal/31-4, Galcd-3Gal/31-4 or Gal~l-4 as deter- 
mined  previously by  methylation  analysis  and  fast  atom 
bombardment (Fig.  1) (Dennis et al.,  1986). To reconstruct 
the Gal/31-4 termini, the unsubstituted GlcNAc residues on 
viable D36W25 cells were substituted using bovine milk/31-4 
galactosyltransferase and UDP-Gal (Torres and Hart, 1984). 
The conditions for galactosylating the cell surface were op- 
timized using UDP-[3H]Gal (Fig. 3).  Saturating conditions 
were attained with the UDP-Gal concentrations fixed at 150 
ttm, GaI-T concentration at 900 mU/ml with  107 D36W25 
cells/ml. A 20-min incubation at 37°C was sufficient to com- 
plete the galactosylation reaction. The amount of Gal added 
was 82 and 2 pmol/105  cells for D36W25  and MDAY-D2, 
respectively.  Separation  of labeled-cell  lysates  by  SDS- 
PAGE showed that for D36W25, multiple cell surface glyco- 
proteins were galactosylated, while at the same exposure 
none were apparent in MDAY-D2 cells treated with GaI-T 
(Fig. 4). Bovine Gal-T will not substitute GalNAc- or glu- 
cose (Brew et al.,  1968), which are the predominant termi- 
nal residues found in O-linked and in glycolipids, respec- 
tively, of D36W25  cells (Lafert6 et al.,  1987).  Therefore, 
based on the specificity of the enzyme and the possible ac- 
ceptors on D36W25 cells, most of the added Gal was likely 
present on N-linked oligosaccharides. 
The efficiency of galactosylation was monitored by assess- 
ing the level of  unsubstituted GlcNAc remaining on D36W25 
cells  after the  galactosylation procedure.  The cells  were 
reacted with Bandeiraea  simplicifolia  (BSII)  lectin and a 
fluoresceinated second antibody and analyzed by FACS. BSII 
lectin recognizes unsubstituted GlcNAc (Ebisu et al.,  1978) 
and bound avidly to D36W25 cells producing a mean fluo- 
rescence intensity of 272.9 (Fig. 5 A). After galactosylation, 
this was reduced to 6.5, while for MDAY-D2 cells, the value 
was 1.1. This suggests that the majority (i.e., 97 %) of the cell 
surface GlcNAc, which was accessible to BSII, had been 
galactosylated by Gal-T.  Galactosylation of D36W25  cells 
increased leucoagglutinin (L-PHA) binding as indicated by 
a  shift in fluorescence intensity from  17.8 to 42.4 (Fig.  5 
B). L-PHA has been shown to bind to Gal~I-4GlcNAc~-2 
(Gal/31-4GIcNAc/5'I-6)  Manet (Cummings and Kornfeld, 1982), 
and, as expected, the addition of Gal to D36W25 enhanced 
L-PHA binding to the cells. 
The turnover rate of galactosylated glycoproteins was esti- 
mated by monitoring the progressive recovery of BSII bind- 
ing sites on the surface of galactosylated D36W25 cells at 
37°C (Fig. 6). The increase in BSII binding as a function of 
time appeared to be multiphasic with 10% recovery in 1 h, 
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Figure 4. SDS-PAGE of D36W25 
and MDAY-D2 protein lysates af- 
ter exogenous galactosylation, us- 
ing 5 #Ci UDP-[3H]Gal and opti- 
mized reaction conditions. 
30% recovery in 8 h and 80% recovery 12 h. These results 
suggest that the majority of the Gal added to D36W25 cells 
remains on the cell surface for a sufficient duration to mea- 
sure its effects on tumor cell binding to endothelial cells in 
vitro and on organ colonization in vivo. 
Exogenous Galactosylation of  D36W25 Cells Increases 
Their Adhesion to Endothelial Cells 
The galactosylated D36W25  cells were found to be nearly 
2 ×  more adhesive to endothelial cell monolayers than mock- 
treated  D36W25  cells  (Fig.  7).  Moreover,  addition  of 83 
/~g/ml of lactosamine-conjugated HSA as a competitive in- 
hibitor,  reduced adhesion of galactosylated cells to that of 
mock-treated D36W25 cells. At this concentration, the Gal 
coupled to the neoglycoprotein was  ~100×  that added to 
the  D36W25  by exogenous galactosylation.  However, lac- 
tosamine-HSA had no effect on the basal level of D36W25 
binding to endothelial cells.  These results suggest that the 
Gal~l-4 added to D36W25 cells is a ligand for a Gal-binding 
lectin on the surface of endothelial cells. 
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Figure 5. Flow cytometry analysis of cell surface BSII (A and C) 
and L-PHA (B and D) binding to D36W25 (A and B) and MDAY-D2 
(C and D) before (open) and after (closed) exogenous galactosyla- 
tion. The mean fluorescence intensity for each distribution has been 
converted to a linear  scale and is indicated on the abscissa. 
Exogenous Galactosylation of  D36W25 Cells Increases 
Their Organ Colonization Potential In Vivo 
MDAY-D2  tumor cells and  B16F10  melanoma cells when 
grown in the presence of swainsonine before their injection 
into the circulation of mice show loss of organ colonization 
potential (Humphries et al.,  1986;  and Dennis,  1986b).  In 
addition,  swainsonine-treated B16F10  cells were more rap- 
idly cleared from the lungs than untreated cells during the 
first 8 h after their injection (Humphries et al., 1986). These 
observations suggest that complex type N-linked oligosac- 
charides on the tumor cells may participate in organ reten- 
tion, possibly by binding to endothelial cell receptors. To de- 
termine  whether  ~l-4Gal  contributed  to  this  phenomena, 
tumor cells were labeled with m25I-UdR  and injected into the 
lateral tail vein of DBA/2 mice to measure the retention or 
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Figure 6.  Turnover of galactosylated cell surface glycoconjugates 
monitored  at 37°C  by reoccurrence  of BSII lectin binding  sites. 
BSII-binding is reported as linear mean value of fluorescence inten- 
sity versus the time of incubation postgalactosylation.  The initial 
BSII binding  intensity of GaI-D36W25 (---) and the native BSII 
binding  intensity of the untreated D36W25 (--) are represented. 
Error bars represent  SD about the mean for triplicate determina- 
tions. 
clearance rates in the lung and liver (Table I). In the first few 
minutes after tumor cells were injected, the majority of ra- 
dioactivity was found in the lungs and ,080-90% of the cells 
were lost from the lungs after 90 min. Although similar num- 
ber of cells arrived in the lungs, ,03 x  as many galactosylated 
D36W25 cells compared to mock-treated cells remained in 
the lung after 90 min, and this difference was maintained at 
23 h (Table II). In the liver, tumor cells accumulated for the 
first 10 min after injection to a maximum of 20%, and were 
then lost over the following 23 h.  Although differences be- 
tween galactosylated-D36W25 and mock-treated cells were 
not observed until  15 h  after injection,  galactosylation did 
increase liver retention ,01.6-fold by 23 h. The differences in 
liver retention between control and galactosylated cells may 
be less pronounced than  in the lung because of the lower 
number of cells that reach the liver. Secondly, most of these 
cells have already passed through the microvasculature of the 
lung where selective retention based on/~l-4Gal content may 
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Figure 7. Inhibition of galactosylated D36W25 cells to endothelial 
monolayer  by  100 ng/ml  lactosamine-HSA.  The bars are (open 
bars)  mock-treated  D36W25 ceils;  (striped  bars)  mock-treated 
D36W25 ceils plus lactosamine-HSA;  (solid bars) Gal-D36W25 
cells;  (stippled bars) Gal-D36W25 cells plus lactosamine  HSA. 
Table I. 
A. Lung Retention 
D36W25  Gal-D36W25 
Time  cpm  %  cpm  % 
5 min  16,580 +  960  86.3 +  5.0  16,218 5:1,300  78.9 +  6 
10 min 11,246 5:922  58.9  5:5.2  13,354 5:656  65.0 5:3.2 
30 min  3,820 5:400  20.0  5:2.1  5,790 5:246  28.2  5:1.2 
90 min  952 5:228  4.9  5:1.2  3,908 5:1,278  19.0 +  6.2 
15 h  76 5:19.6  0.4  5:0.1  154 5:10  0.75 5:0.05 
23 h  32 5:4  0.17  5:0.02  89 5:19.3  0.43 5:0.1 
B. Liver Retention 
D36W25  GaI-D36W25 
Time  cpm  %  cpm  % 
5  min  1,315  +  400  6.9  +  2.1  1,765  +  369  8.6  +  1.8 
10min  3,622  +610  19.0  +  3.2  4,106  +  554  20.0  +2.7 
30  min  1,601  5:248  8.4  5:1.3  1,765  5:123  8.6  5:0.7 
90  min  838  +  267  4.4  5:1.4  1,088  5:182  5.3  5:0.89 
15  h  78  5:11  0.41  5:0.06  127  +  8.2  0.62  +  0.04 
23  h  32  5:1.9  0.17  5:0.01  55  +  3  0.27  5:0.015 
Organ  retention  of  1251UdR-labeled D36W25  and  galactosylated  D36W25 
cells.  The inoculum of D36W25 cells contained  19,063 cpm,  and,  for Gal- 
D36W25, the inoculum contained 20,530 cpm. Background of 16.5 cpm was 
subtracted.  The fraction of cells retained in the lung or liver were calculated 
from the  radioactivity  remaining  in the  organs as a percentage  of the total 
radioactivity in the cell inoculum. The results for each time point are the mean 
:i: SD for three mice. Analysis of variance on the log-transformed data indicat- 
ed that retention of GaI-D36W25 cells in the lung and liver was significantly 
reduced;  P  =  0.001,  and P  =  0.002,  respectively. 
have already occurred. Although galactosylation of D36W25 
cells improved their retention in the liver and lung, retention 
of  wild-type  MDAY-D2  cells  was  approximately  twofold 
greater than that of the galactosylated D36W25 cells at 15 h 
(Fig. 8). This suggests that fll-4Gal is only part of the carbo- 
hydrate structure  on MDAY-D2  cells that facilitates organ 
retention. 
/31-4Gal binding lectins on the surface of some tumor cell 
lines have previously been shown to agglutinate tumor cells 
in the presence of asialofetuin  (Raz,  1987).  However, the 
galactosylated D36W25 cells did not agglutinate alone or in 
the presence of increasing concentrations of asialofetuin or 
serum suggesting that formation of tumor cell aggregates via 
this mechanism was not likely responsible for increased or- 
gan retention or colonization (data not shown). 
Galactosylated D36W25, control D36W25, and wild-type 
MDAY-D2  cells  were  injected  intravenously  into  DBA/2 
Table II. Liver Colonization by MDAY-D2, D36W25, and 
GaI-D36W25 Cells 
No.  of mice with 
liver metastases/  Mean no. of 
Cells  no.  injected  nodules/mouse  (range) 
MDAY-D2  18:18  (100%)  >100 
D36W25  3:20  (10%)  0.26  (0-4) 
D36W25  +  UDP-Gal  0:10  (0)  0 
GaI-D36W25  12:18  (67%)  8.6  (0-40) 
Syngeneic DBA/2 mice were injected intravenously with l0  s lymphosarcoma 
cells and liver nodules were counted 3-4 wk later.  Mocked-treated  D36W25 
cells were treated with UDP-Gal alone and are designated D36W25  +  UDP- 
Gal.  Galactosylated D36W25 cells are designated GaI-D36W25. 
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Figure 8.  Organ retention of [~25I]UdR-labeled MDAY-D2, D36- 
W25, and galactosylated D36W25 ceils at 15 h after intravenous 
injection of the tumor cells. The bars are (open bars) mock-treated 
D36W25 cells;  (striped  bars)  GaI-D36W25 cells;  (solid  bars) 
MDAY-D2 cells. The results are the percent of ~25I-labeled cells 
retained in the lungs and liver for three mice (mean +  SD). 
mice, and the mice were examined 4 wk later to determine 
whether added Gal would increase the number of metastatic 
tumor nodules in the organs (Table II). Mice injected with 
MDAY-D2  cells invariably showed hundreds of liver nod- 
ules, and, at much lower frequency, lung, kidney, and spleen 
metastases, whereas mice injected with D36W25 ceils were 
rarely  affected,  as  previously  reported  (Dennis,  1986a). 
The mean number of tumor nodules in D36W25-injected 
mice was 0.26 with a range of 0-4 nodules. In contrast, galac- 
tosylated D36W25  cells  showed a  30-fold increase in the 
number of nodules found in the liver. The addition of Gal to 
D36W25 cells significantly increased the efficiency of liver 
colonization, but this was at least an order of magnitude less 
than that observed for the wild-type cells MDAY-D2. 
Discussion 
The binding of circulating tumor cells to microvessel en- 
dothelial cells has been suggested to be a significant factor 
in the initial retention of tumor cell in specific organs (Nicol- 
son,  1988).  Subsequent  events,  tumor cells  invasion and 
growth of  the cells in a particular tissue environment are also 
thought to be important factors controlling the establishment 
of metastases. In this report, we have found that a somatic 
mutation that blocks addition of Gal and SA to cellular gly- 
coconjugates, as well as two chemical inhibitors of N-linked 
processing, impaired tumor cell adhesion to endothelial cells 
in vitro. A  similar loss of adhesiveness to endothelial cells 
was also observed for the class 1 type mutation of the human 
MeWo melanoma cell line called 3S5 (Ishikawa et al., 1988) 
(data not shown). The addition of/31-4Gal to the N-linked 
oligosaccharides on the surface of the glycosylation mutant 
(i.e., D36W25) partially restored adhesion of the cells to en- 
dothelial cell monolayers. The Gal-dependent adhesion was 
inhibited by the addition of lactosamine-HSA,  suggesting 
that the/~l-4Gal restored to the cell surface served as a ligand 
for a  mammalian lectin found on the endothelial cells.  In 
vivo, the galactosylated D36W25 cells showed increased or- 
gan retention and  colonization compared to mock-treated 
D36W25 cells. The relationship between the cell lines for en- 
dothelial cell adhesion, organ retention and organ coloniza- 
tion was  consistent and proportionate:  MDAY-D2  >  Gal- 
D36W25  >  D36W25.  Swainsonine-  and  castinospermine- 
treated MDAY-D2 cells were also intermediate between 
MDAY-D2 and D36W25 for adhesion to endothelial ceils in 
vitro,  and,  as  previously shown,  the  drugs  inhibit  organ 
retention and colonization (Schaaf-Lafontaine, 1985; Hum- 
phries et al.,  1986; Dennis,  1986b). 
Since galactosylation of mutant D36W25 cells does not 
completely restore endothelial cell adhesion and organ re- 
tention to the level observed for wild-type MDAY-D2 cells, 
it is likely that more complex sequences containing B1-4Gal 
participate in MDAY-D2 adhesion to endothelium.  Unlike 
the galactosylated D36W25 cells, a large portion of the ~l- 
4Gal in N-linked oligosaccharides of MDAY-D2 cells is not 
terminal  but  rather  found  in  polylactosamine sequences 
(i.e., Galfll-4GlcNAc repeating sequences) and substituted 
(i.e., SAc~2-3GalI31-4, Gai~l-3Gal~l-4 or Gai~l-4) (Fig.  1) 
(Dennis et al.,  1986).  Calf heart lectin has been shown to 
bind more avidly to polylactosamine sequences than to sim- 
ple lactosamine antenna (Merkle and Cummings, 1988). En- 
dothelial cells  may have a  lectin with  similar  specificity 
where the ~l-4Gal is part of a larger ligand structure. Under- 
sialylated glycosylation mutants  of the murine B16  mela- 
noma have also been reported to be less adhesive to endothe- 
lial cell monolayers (Tao and Johnson, 1982), suggesting that 
sialic acid may also be part of the ligand. Experiments are 
in progress to examine this possibility. 
In addition to direct adhesion of tumor ceils to endothelial 
cells, galactosylation of D36W25 cells may enhance hetero- 
typic interactions with platelets (Gartner et al.,  1978), lym- 
phocytes (Parrish et al.,  1984), and even with hepatocytes 
and  Kupffer ceils  (Schirrmacher et al.,  1980;  Schlepper- 
Schafor et al., 1980) on which Gal-binding lectins have pre- 
viously been detected (Ashwell and Harford, 1982). These 
interactions in addition to endothelial cell binding, may cu- 
mulatively contribute to the observed enhancement of organ 
retention and colonization in vivo by galactosylated D36W25 
cells. 
Since the relative difference in adhesiveness of D36W25 
and galactosylated D36W25 cells was observed on both bo- 
vine adrenal microvascular and human cord macrovascular 
endothelial  cells,  the  ill-4  Gal  component of recognition 
does not appear to be organ specific. Although there may be 
a lack of organ specificity in the Gal-mediated adhesion to 
endothelium, there was a clear preference for the MDAY-D2 
lines to produce colonies in the liver rather than the lungs. 
The growth of visible nodules may be more related to a 
preference for the growth environment of the liver, rather 
than to retention of tumor cells in a specific organ. In this 
regard,  murine lymphosafcoma cell lines such as MDAY- 
D2,  Esb,  and Friend virus leukemia cells (Kerbel,  1980; 
Schirrmacher et al., 1979; Belardelli et al., 1984) appear to 
grow preferentially in the liver. 
Somatic mutations that impair complex type N-linked oli- 
gosaccharide processing in tumor cells (Finne et al.,  1982; 
Ishikawa et al., 1988; Dennis, 1986a,b) as well as chemical 
inhibitors of processing have been shown to reduce metas- 
tatic potential in several experimental tumor models. In par- 
ticular, the degree of -GlcNAc/31-6Manod-6Man~l-branching 
and the completion of these structures with SAa2-3Gal~l-4 
appears to be closely associated with metastatic ability (Dennis 
et al., 1987; Dennis et al., 1989). Based on these experimental 
systems, the complex type N-linked oligosaccharides in me- 
tastatic cells appear to contribute to decreased cell adhesion 
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ness of human amnion basement membranes in vitro (Lafert6 
and Dennis, 1988; Yagel et al., 1989). In addition, the oligo- 
saccharides are associated with increased responsiveness to 
autocrine growth stimulation (VanderElst, I., and J. W. Den- 
nis, manuscript submitted for publication). Invasion and cell 
proliferation are events that would not occur or be completed 
before the exogenously added/31-4Gal had been replaced by 
membrane turnover (Crissman et al., 1985). Therefore, even 
if exogenous glycosylation were able to restore organ reten- 
tion to that of the wild-type cells, the number of organ nod- 
ules observed several weeks later might be not be restored. 
If the oligosaccharide sequences required for wild-type lev- 
els of  endothelial cell adhesion could be restored to D36W25 
cells by exogenous glycosylation with several transferases, it 
should be possible to test this hypothesis directly. 
Finally, the class 1 glycosylation  mutants lack polylactosa- 
mine that form the basis for synthesis of many of the blood 
group  and  embryonic antigens  (Hakamori  and  Kannagi, 
1983).  Therefore,  when the  purified  glycosyltransferases 
necessary for synthesis of these sequences become available, 
the mutants could be exogenously glycosylated with several 
monosaccharide residues to create a variety of structures. 
This approach should help define the carbohydrate speci- 
ficity of cell surface lectins and the role of both ligand and 
receptor in cell-cell interactions. 
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